Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/10244| Title: | Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? |
| Authors: | Amorim, Viviane Brandão Parente, Daniella Braz Paiva, Fernando Fernandes Oliveira Neto, Jaime Araújo Miranda, Amanda Almeida Moreira, Cláudia Cravo Fernandes, Flávia Ferreira Campos, Carlos Frederico Ferreira Leite, Nathalie Carvalho Perez, Renata de Mello Rodrigues, Rosana Souza |
| Keywords: | Fígado Gorduroso Fatty Liver Hepatopatia Gordurosa não Alcoólica Non-alcoholic Fatty Liver Disease Gadolínio DTPA Gadolinium DTPA |
| Issue Date: | 2020 |
| Publisher: | World J Hepatol |
| Citation: | AMORIM, Viviane Brandão et al. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol, v. 12, n. 9, p. 661-671, 2020. |
| Abstract: | Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. The diagnosis of nonalcoholic steatohepatitis (NASH), the most severe form of NAFLD, is crucial and has prognostic and therapeutic implications. However, currently this diagnosis is based on liver biopsy and has several limitations. |
| Description: | p. 661-671.: il. p&b. |
| URI: | http://sr-vmlxaph03:8080/jspui/handle/123456789/10244 |
| ISSN: | 1948-5182 |
| Appears in Collections: | Artigos de Periódicos da área de Radiologia |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver.pdf | 1.88 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.